Drawing for WID

USPTO serial 97150184

WID

Reviewed by CopyMark Law Group

Reg. 7307764Status 700Registered
Filing date
Status date
Registration date
Feb 20, 2024
Examiner
NELMAN, JESSE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Mueller

John Mueller BAKER & HOSTETLER LLP312 Walnut StreetSuite 3200Cleveland, OH 45202-4074

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervix, uterine body, ovary and breast; diagnostic kits comprised of medical assays for testing bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers; diagnostic reagents in kit form consisting of kits comprised primarily of diagnostic reagents for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluids, bodily tissue and blood for the diagnosis and detection of cancer; diagnostic reagents and kits of comprised primarily of diagnostic reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for medical diagnostic useACTIVE
010Medical apparatus for diagnostic testing of biological samples, namely, bodily fluids, body tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluids, bodily tissue and blood; instruments for making cervical smears; DNA and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations in relation to gynecological cancers of the cervix, uterine body, ovary and breastACTIVE
042Scientific research for chemical, biochemical, biological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations, and for detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancerACTIVE
044Medical diagnostic services; medical testing services relating to the diagnosis and treatment of diseases; medical diagnostic testing relating to the human body; blood testing services; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; consultancy, advisory and information services relating to medical research and development in the field of cancer diagnosis and detectionACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 18, 2023RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Oct 18, 2023RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Oct 18, 2023RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Oct 17, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 19, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jul 19, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 19, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2023ALIEASSIGNED TO LIE
Mar 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2022DOCKASSIGNED TO EXAMINER
Dec 6, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance